Everest Organics informs about disclosure

19 Feb 2021 Evaluate
Everest Organics has informed that it has enclosed the disclosure received from the acquirer BK Advance Research, LLP, PAC of the Company in Form 29(2) under Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 and Form C under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.


Everest Organics Share Price

123.35 7.80 (6.75%)
05-Jun-2024 12:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1478.65
Dr. Reddys Lab 5827.25
Cipla 1507.40
Zydus Lifesciences 1055.25
Lupin 1613.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.